Skip to content

CL PHARMA

Absorbed by MULTIPHARMA on 09-06-2022 KBO/BCE: BE 0832.441.825

Lifetime

11 annual accounts with figures on one time axis
peak of €147,590 in 2019
€58,424▼ 57.4%
lowest -€87,604 in 2020
-€49,182▲ €38,422
peak of €299,418 in 2018
€116,797▼ 29.6%
€662,250▼ 12.1%
peak of 1 FTE in 2019
-not published
Board2 names since 2020
1 director
Owners2 names in the annual accounts
100% and 1 other
Documentsfilings and deeds
22-06-202239 days before the deadline
2021financial year
Gross margin from €137,073 to €58,424Loss of €49,182Registered office moved from Seneffe to Anderlecht 25-01Equity from €165,980 to €116,797Cash from €19,301 to €54,553

Key points

from the 2021 annual accounts, the last ones filed

Equity

€116,797 from €299,418 in 2018

Equity fell by 61% in 3 years.

Debts

€662,250 85% of the balance sheet
Suppliers 1%Taxes and wages 0%Other 99%

Filings

11 annual accounts since 2011
AprilJune31 JulyOctober20152020

Two of the last ten came late. The 2017 accounts came in latest, 22 days after the end of the period.

Board and ownership

Director, since 07-12-2020
Auditor,
Board & ownership

Recent changes

Merger: absorbed by MULTIPHARMA Dissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares · General meeting of 09-06-2022 · Gazette deed
Merger proposal: to be absorbed by MULTIPHARMA Gazette deed
Registered office moved from Seneffe to Anderlecht The registered office moved from Bois de Sapins, 8-7181 Seneffe to Square Marie Curie, 30 à 1070 Anderlecht · resigns as manager · (director) and (statutory auditor) appointed · General meeting of 07-12-2020 · Gazette deed
Merger: Pharmacie C.L. Pharmagest takes over PHARMACIE D. CULLUS Company renamed from Pharmacie C.L. Pharmagest to CL PHARMA · Cancellation of 250 shares · The company holds all the shares of PHARMACIE D. CULLUS · General meeting of 22-01-2019 · Gazette deed
All 21 events

Official details

Source: KBO
Status
Absorbed by MULTIPHARMAmerger by absorption, June 2022
Activity
“L'achat, la vente, la construction, la transformation, la mise en valeur, la location ou…” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO
Joint committee
313Pharmacies and pricing offices · annual accounts 2021
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2021

≈ €170,000estimated
€779,047▼ 15.3%
Filing
Filed on 22-06-2022
Financials

Insights on CL PHARMA

Absorbed by MULTIPHARMA in June 2022. The last annual accounts are for financial year 2021. The company was dissolved without liquidation.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CL PHARMA

What is the company number of CL PHARMA?
The company number of CL PHARMA is 0832.441.825. The VAT number is the same number with BE in front: BE 0832.441.825.
What is the legal form of CL PHARMA?
The KBO register gives CL PHARMA the legal form “SRL”.
Is CL PHARMA still active?
No. Absorbed in a merger on 09-06-2022.Company details
How many employees did CL PHARMA have?
CL PHARMA had an average of 0.9 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
Which joint committee does CL PHARMA fall under?
In its 2021 annual accounts, CL PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of CL PHARMA?
The turnover in financial year 2021 is about €170,000. This figure is estimated from the gross margin of €58,424 and 992 comparable companies of the same size. It probably lies between €100,000 and €340,000. It is a rough estimate.
Is CL PHARMA profitable?
In financial year 2021, CL PHARMA made a loss of €49,182.
Where can I find the annual accounts of CL PHARMA?
CL PHARMA filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2021.

Next steps

Keep this company with today's facts in a case file.